OssDsign

OssDsign is a Swedish medical technology company focused on products used in spine surgery and orthobiology. The group operates through OssDsign AB and its subsidiaries in the U.S., the U.K. and Scotland, with sales activities conducted through OssDsign USA Inc.

— OssDsign
%
Spine orthobiology70% Bone graft and fusion products used in spinal procedures.
Cranial implants20% Patient-specific cranial implant solutions for neurosurgical reconstruction.
Clinical and commercial support10% Clinical evidence generation, education and market support around products.

OssDsign sells primarily to hospitals, surgeons and healthcare systems that perform spine and cranial procedures...

  • Hospitals and healthcare systemsprimary

    Buy products for surgical departments that treat spine and cranial reconstruction cases.

  • Spine surgeonsprimary

    Use OssDsign Catalyst in fusion procedures where clinical evidence and handling matter.

  • Neurosurgeonssecondary

    Use Cranial PSI for patient-specific cranial reconstruction cases.

  • Orthobiology distributors and channel partnerssecondary

    Support market access and product placement in selected geographies.

OssDsign is headquartered in Uppsala, Sweden, but its commercial footprint is centered in the United States...

  • •U.S. is the disclosed revenue market in the reports
  • •Head office and parent company are based in Uppsala, Sweden
  • •Sales activities are conducted through OssDsign USA Inc
  • •Subsidiaries in England and Scotland support the group structure

OssDsign’s strategy centers on building clinical evidence around OssDsign Catalyst and using that evidence to expand...

01
Clinical evidence generationshort-term

Published outcomes help differentiate the products in a crowded medtech market.

02
U.S. commercial expansionmedium-term

The U.S. is the core revenue market and the main platform for scaling adoption.

03
Product portfolio expansionmedium-term

A broader offering can increase procedure coverage and customer relevance.

OssDsign faces typical medtech risks tied to regulation, product liability, intellectual property and clinical adoption...

high

Regulatory and licensing risk

Medical devices must meet government and industry requirements before sale and use.

Scope
Product development and commercialization
Materiality
high
high

Product liability risk

Implantable products can create claims if outcomes or safety are challenged.

Scope
Clinical use and post-market surveillance
Materiality
high
high

Future financing risk

Growth and product development can require external capital before cash generation.

Scope
Corporate funding and expansion plans
Materiality
high
medium

Intellectual property risk

The company depends on patents and know-how to protect its products.

Scope
Catalyst and cranial implant portfolio
Materiality
high
medium

Foreign exchange risk

Operations and sales span SEK, USD and other currencies.

Scope
U.S. sales and group reporting
Materiality
medium
Capitalized development costs
Reported operating expenses and intangible assets
Impairment testing of intangibles
Potential write-downs of goodwill or development assets
Revenue timing and intra-group sales
Quarterly comparability and revenue recognition timing
Foreign exchange translation
Reported revenue, gross margin and operating result

ENSIGN GROUP, INC

ENSG · Services-Skilled Nursing Care Facilities

OFS Capital Corp

OFS

Odyssey Health, Inc.

ODYY · Surgical & Medical Instruments & Apparatus

OS Therapies Inc

OSTX · Pharmaceutical Preparations

4D Molecular Therapeutics, Inc.

FDMT · Biological Products, (No Diagnostic Substances)

Direct Digital Holdings, Inc.

DRCT · Services-Advertising

: 11/08/2026